Research in Action
A podcast by Oracle Corporation

Categories:
31 Episodes
-
AI's Role in Cancer Care Today and Tomorrow
Published: 20/08/2024 -
Transforming public health with unstructured data and NLP in FDA's Sentinel Initiative
Published: 23/07/2024 -
Empowering Patient-Centered Research Through Technology and Engagement
Published: 9/07/2024 -
Advancing clinical research through tech and teamwork
Published: 4/06/2024 -
How Innovation is Redefining Health and Life Sciences
Published: 22/05/2024 -
Exploring New Frontiers in Pharma: Mindsets, Data, AI, and Oracle
Published: 30/04/2024 -
Unlocking Innovation Through Public, Private, and Academic Partnerships
Published: 16/04/2024 -
Advancing scientific discovery with patient-led research
Published: 19/03/2024 -
Bringing clinical research into everyday patient care
Published: 5/03/2024 -
Building patient-friendly access to clinical trials
Published: 20/02/2024 -
Data hippies, real-world evidence, and precision medicine
Published: 6/02/2024 -
Advancing rare disease research with a patient-centered approach
Published: 24/01/2024 -
Automation, innovation, and the future of drug safety
Published: 9/01/2024 -
Patient empowerment, digital innovation, and rare diseases
Published: 5/10/2023 -
Biotech startup working with Oracle to innovate for pharma
Published: 20/09/2023 -
Science, Research, and Reaching the UN SDGs
Published: 6/09/2023 -
Talking AI, Computer Vision, Autism, and Small Data Problems
Published: 16/08/2023 -
Cloud technology’s impact on epidemiology research and public health
Published: 12/07/2023 -
Transforming healthcare research with technology's latest capabilities
Published: 28/06/2023 -
The rise of research entrepreneurs and why it matters
Published: 14/06/2023
"Research in Action" explores the dynamic world of life sciences, covering drug discovery, clinical trials, therapeutic development, and the pivotal role of real-world data and technology in connecting clinical research with patient care. Hear insightful conversations with scientists, clinicians, and leaders from pharma, biotech, and health.